BBC follows Manchester CRF patient on cancer research study
In December 2019 BBC North West Tonight followed Dave and his wife Amanda, on his journey through a clinical research trial at NIHR Manchester CRF at The Christie.
Read moreNews & Events category:
NIHR Manchester Clinical Research Facility
From placement to PhD? – A Manchester BRC research placement story
Clinical pharmacist Jake Doherty shares how his six-week NIHR Manchester Biomedical Research Centre TRACE-COPD study placement has opened his eyes to new possibilities for a research career.
Read more
The gift of research
Rhodri Evans, a patient in a peanut allergy study at Manchester Clinical Research Facility shares his insight into living with peanut allergy, and how he now believes in the gift of research.
Read more
Saint Mary’s Hospital surgical team wins national award for cancer research
A surgical team at Saint Mary’s Hospital recently received a prestigious national award for their role in surgical trials for cancer research.
Read more
First patient in Europe recruited in a peanut allergy trial for children under four years old
Manchester Clinical Research Facility has successfully recruited the first patient in Europe, in a peanut allergy study in children under four years old.
Read more
Can we win the fight against sepsis and antibiotic resistance?
On World Sepsis Day Dr Timothy Felton discusses the challenge of tackling sepsis in the face of the increasing challenge posed by antibiotic resistance.
Read more
First patient treated in global gene therapy trial at Manchester CRF at MRI
The NIHR Manchester CRF at Manchester Royal Infirmary has successfully dosed the first patient in the UK and the first patient to Cohort 2 Globally to phase 1 gene therapy trial.
Read more
First patient in the world recruited to cystic fibrosis inhaled anti-fungal therapy trial
Manchester Adult Cystic Fibrosis Centre has recruited the first patient in the world to a research study investigating a new anti-fungal drug. The trial is being conducted at Manchester CRF.
Read more
